Findlay Park Partners LLP bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,312,063 shares of the medical research company’s stock, valued at approximately $174,281,000. Agilent Technologies makes up approximately 2.4% of Findlay Park Partners LLP’s portfolio, making the stock its 19th largest position.
Several other large investors have also recently bought and sold shares of A. Brighton Jones LLC boosted its holdings in shares of Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares during the last quarter. Jones Financial Companies Lllp increased its holdings in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. increased its holdings in Agilent Technologies by 54.8% during the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after buying an additional 212 shares during the last quarter. Acadian Asset Management LLC raised its position in Agilent Technologies by 16.5% during the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after acquiring an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in Agilent Technologies during the second quarter worth $273,000.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on A shares. Robert W. Baird lifted their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Sanford C. Bernstein began coverage on Agilent Technologies in a report on Friday, June 26th. They set an “outperform” rating and a $155.00 price target for the company. Finally, Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.
Agilent Technologies Price Performance
Shares of A opened at $159.25 on Friday. The business has a 50-day moving average of $137.57 and a 200-day moving average of $126.23. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The company has a market capitalization of $44.98 billion, a price-to-earnings ratio of 31.98, a price-to-earnings-growth ratio of 2.81 and a beta of 1.25. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.51.
Agilent Technologies (NYSE:A – Get Free Report) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same quarter in the prior year, the firm posted $1.31 EPS. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current year.
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
